Veloxis Pharms Inc Drug Patent Portfolio

Veloxis Pharms Inc owns 1 orange book drug protected by 24 US patents Given below is the list of Veloxis Pharms Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8644239 Method and apparatus for allocating and processing sequences in communication system 30 Aug, 2028
Active
US8664239 Tacrolimus for improved treatment of transplant patients 30 Aug, 2028
Active
US8685998 Tacrolimus for improved treatment of transplant patients 30 Aug, 2028
Active
US10166190 Stabilized tacrolimus composition 30 May, 2028
Active
US10864199 Tacrolimus for improved treatment of transplant patients 30 May, 2028
Active
US11110081 Tacrolimus for improved treatment of transplant patients 30 May, 2028
Active
US11123331 Tacrolimus for improved treatment of transplant patients 30 May, 2028
Active
US11419823 Stabilized tacrolimus composition 30 May, 2028
Active
US12083103 Tacrolimus for improved treatment of transplant patients 30 May, 2028
Active
US9549918 Stabilized tacrolimus composition 30 May, 2028
Active
US10548880 Solid dispersions comprising tacrolimus 30 Aug, 2024 Expired
US11077096 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US7994214 Solid dispersions comprising tacrolimus 30 Aug, 2024 Expired
US8486993 Solid dispersions comprising tacrolimus 30 Aug, 2024 Expired
US8586084 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US8591946 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US8617599 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US8623410 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US8623411 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US8889185 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US8889186 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US9161907 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US9757362 Modified release compositions comprising tacrolimus 30 Aug, 2024 Expired
US9763920 Solid dispersions comprising tacrolimus 30 Aug, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Veloxis Pharms Inc.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 10 Jul, 2024 US9549918
Payment of Maintenance Fee, 4th Year, Large Entity 29 May, 2024 US10864199
Payment of Maintenance Fee, 4th Year, Large Entity 19 Jul, 2023 US10548880
Payment of Maintenance Fee, 8th Year, Large Entity 05 Apr, 2023 US9161907
Payment of Maintenance Fee, 12th Year, Large Entity 25 Jan, 2023 US7994214
Recordation of Patent Grant Mailed 23 Aug, 2022 US11419823
Patent Issue Date Used in PTA Calculation 23 Aug, 2022 US11419823
Email Notification 04 Aug, 2022 US11419823
Issue Notification Mailed 03 Aug, 2022 US11419823
Mailing Corrected Notice of Allowability 26 Jul, 2022 US11419823
Email Notification 26 Jul, 2022 US11419823
Corrected Notice of Allowability 21 Jul, 2022 US11419823
Pubs Case Remand to TC 17 Jul, 2022 US11419823
Dispatch to FDC 11 Jul, 2022 US11419823
Application Is Considered Ready for Issue 11 Jul, 2022 US11419823


Veloxis Pharms Inc's Family Patents

Veloxis Pharms Inc drugs have patent protection in a total of 24 countries. It's US patent count contributes only to 34.3% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Veloxis Pharms Inc Drug List

Given below is the complete list of Veloxis Pharms Inc's drugs and the patents protecting them.


1. Envarsus Xr

Envarsus Xr is protected by 24 patents, out of which 14 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8644239 Method and apparatus for allocating and processing sequences in communication system 30 Aug, 2028
(3 years from now)
Active
US8664239 Tacrolimus for improved treatment of transplant patients 30 Aug, 2028
(3 years from now)
Active
US8685998 Tacrolimus for improved treatment of transplant patients 30 Aug, 2028
(3 years from now)
Active
US10166190 Stabilized tacrolimus composition 30 May, 2028
(3 years from now)
Active
US10864199 Tacrolimus for improved treatment of transplant patients 30 May, 2028
(3 years from now)
Active
US11110081 Tacrolimus for improved treatment of transplant patients 30 May, 2028
(3 years from now)
Active
US11123331 Tacrolimus for improved treatment of transplant patients 30 May, 2028
(3 years from now)
Active
US11419823 Stabilized tacrolimus composition 30 May, 2028
(3 years from now)
Active
US12083103 Tacrolimus for improved treatment of transplant patients 30 May, 2028
(3 years from now)
Active
US9549918 Stabilized tacrolimus composition 30 May, 2028
(3 years from now)
Active
US10548880 Solid dispersions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US11077096 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US7994214 Solid dispersions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US8486993 Solid dispersions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US8586084 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US8591946 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US8617599 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US8623410 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US8623411 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US8889185 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US8889186 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US9161907 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US9757362 Modified release compositions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired
US9763920 Solid dispersions comprising tacrolimus 30 Aug, 2024
(a month ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Envarsus Xr's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List